PremiumThe FlyHSBC to phase out fixed-pay allowance, shift to bonuses model, Bloomberg says6h agoHSBC
PremiumRatingsNovartis: Pipeline and Key Assets Seen Offsetting $20B Patent Headwind; Buy Rating Reiterated with Unchanged $150 Price Target7h agoNVS
Novartis: Pipeline and Key Assets Seen Offsetting $20B Patent Headwind; Buy Rating Reiterated with Unchanged $150 Price Target